I found purpose after my AML diagnosis by reflecting on loss, embracing gratitude and using my experience to help others ...

French biotech ImCheck Therapeutics is preparing to showcase encouraging interim results for its investigational monoclonal ...

Doctors highlighted the need for a comprehensive national strategy to tackle AML and the need for recognising the ...

During a live event, Gary J. Schiller, MD, reviewed the diagnostics and characteristics of blastic plasmacytoid dendritic ...

TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in ...

Don't dismiss persistent fatigue and bruising. These 11 warning signs could indicate acute myelogenous leukemia hiding in ...

These blood cancers all start in the bone marrow, and the research shows that cancer cells depend on taurine from their ...

Priothera is a late-stage biopharma company pioneering the development ... initially on acute myeloid leukemia (AML), in combination with allogeneic hematopoietic cell transplant (allo-HCT).